Xconomy: Alzheimer's disease News, Articles and Opinions

“alzheimers-disease” Archives

Entry	Author	Date	Location
Biogen Reverses Course on Alzheimer’s Drug Analysis, Plans FDA Filing	Sarah de Crescenzo	10/22/19	Boston
Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO	Frank Vinluan	10/01/19	New York
BACEless: Eisai, Biogen Pull Plug on Alzheimer’s Drug in Final Stage	Frank Vinluan	09/13/19	Boston
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More	Frank Vinluan	08/02/19	National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More	Ben Fidler	07/26/19	National
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs	Frank Vinluan	07/11/19	National
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More	Alex Lash	06/07/19	National
Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance	Frank Vinluan	06/04/19	Boston
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials	Frank Vinluan	05/09/19	National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More	Frank Vinluan	04/26/19	National
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience	Ben Fidler	04/24/19	Boston
Alzheimer’s, Gene Therapy & More: Agenda For “What’s Hot” on May 21	Ben Fidler	04/16/19	Boston
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More	Ben Fidler	03/29/19	National
Urovant Bladder Drug Hits Test Goals But Can’t Outpace Generic Rival	Frank Vinluan	03/19/19	San Diego
Voyager Therapeutics, AbbVie Add Parkinson’s to Gene Therapy Pact	Frank Vinluan	02/22/19	Boston
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials	Frank Vinluan	02/06/19	San Francisco
FDA Rejects Alkermes Depression Drug, Asks for More Clinical Data	Frank Vinluan	02/01/19	Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More	Frank Vinluan	02/01/19	National
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test	Ben Fidler	01/30/19	National
Dewpoint Debuts with $60M to Target Protein Droplets Linked to Disease	Corie Lok	01/30/19	Boston
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer	Ben Fidler	01/18/19	National
Tetra Inks Deal with Shionogi to Support Fragile X, Alzheimer’s R&D	Sarah Schmid Stevenson	01/09/19	Detroit Ann Arbor
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs	Frank Vinluan	01/07/19	San Francisco
San Francisco Biotech: The Next Generation—Photos and Takeaways	Frank Vinluan	12/26/18	San Francisco
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More	Alex Lash	12/21/18	National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1)	Ben Fidler	12/17/18	National
Eli Lilly Partners with AC Immune on Tau Blockers for Alzheimer’s	Corie Lok	12/12/18	Indiana
Viracta, Neurelis & More: The Latest in San Diego Biotech	Sarah de Crescenzo	12/05/18	San Diego
Salk Team Awarded 8-Year, $19.2M Grant for Alzheimer’s Research	Sarah de Crescenzo	11/09/18	San Diego
Allogene, Cortexyme & RDMD Headline Xconomy’s Dec. 5 Biotech Forum	Frank Vinluan	11/08/18	San Francisco
Page 1 of 6	next page »